LYMPHOTRACKDX

WIPO WIPO 2015

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark LYMPHOTRACKDX was filed as Word mark on 08/24/2015 at the World Intellectual Property Organization.

Trademark Details Last update: February 24, 2023

Trademark form Word mark
File reference 1266023
Countries Switzerland China em Japan South Korea
Base trademark US No. 86560582, March 11, 2015
Application date August 24, 2015
Expiration date November 12, 2018

Trademark owner

10222 Barnes Canyon Road,
Building 1
US

Trademark representatives

2040 Main Street, 14th Floor Irvine CA 92614 US

goods and services

01 Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use
05 Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
42 DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
44 DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays

Trademark history

Date Document number Area Entry
June 4, 2019 2019/26 Gaz US RAW: Total Ceasing Effect
November 16, 2016 2016/47 Gaz CN Rejection
August 31, 2016 2016/36 Gaz CH Rejection
August 12, 2016 2016/34 Gaz KR Rejection
July 26, 2016 2016/32 Gaz EM Rejection
February 18, 2016 2016/8 Gaz JP Rejection
August 24, 2015 2015/37 Gaz US Registration

ID: 141266023